Sanofi Mature competitive analysis

Latest publications and patents of Sanofi Mature New

Explore the latest publications and patents granted to Sanofi Mature, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sanofi Mature

Mar 10, 2021Novel Antitumoral Use Of CabazitaxelGranted And Under Opposition
Dec 18, 2019Cabazitaxel And Its Use For Treating CancerRevoked
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And CisplatinRevoked

Explore Sanofi Mature's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer9
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Latest PTAB cases involving Sanofi Mature

Discover the latest PTAB cases involving Sanofi Mature, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanofi Mature with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SANOFI MATURE - 23 - - Non-Active
ACCORD HEALTHCARE34 - 4 - Highly Aggressive
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL6 - - - Highly Aggressive
GENERICS UK212 - - - Highly Aggressive